Panasonic Holdings Corporation

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, AAPL has a market cap of 2.96T. Regarding current trading prices, PCRFF is priced at $12.32, while AAPL trades at $198.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas AAPL's P/E ratio is 27.99. In terms of profitability, PCRFF's ROE is +0.05%, compared to AAPL's ROE of +1.51%. Regarding short-term risk, PCRFF is more volatile compared to AAPL. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SSNLF has a market cap of 266.62B. Regarding current trading prices, PCRFF is priced at $12.32, while SSNLF trades at $40.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SSNLF's P/E ratio is 8.44. In terms of profitability, PCRFF's ROE is +0.05%, compared to SSNLF's ROE of +0.09%. Regarding short-term risk, PCRFF is more volatile compared to SSNLF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, XIACY has a market cap of 172.88B. Regarding current trading prices, PCRFF is priced at $12.32, while XIACY trades at $33.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas XIACY's P/E ratio is 51.75. In terms of profitability, PCRFF's ROE is +0.05%, compared to XIACY's ROE of +0.11%. Regarding short-term risk, PCRFF is more volatile compared to XIACY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, XIACF has a market cap of 171.81B. Regarding current trading prices, PCRFF is priced at $12.32, while XIACF trades at $6.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas XIACF's P/E ratio is 51.00. In terms of profitability, PCRFF's ROE is +0.05%, compared to XIACF's ROE of +0.08%. Regarding short-term risk, PCRFF is more volatile compared to XIACF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SNEJF has a market cap of 151.96B. Regarding current trading prices, PCRFF is priced at $12.32, while SNEJF trades at $25.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SNEJF's P/E ratio is 19.40. In terms of profitability, PCRFF's ROE is +0.05%, compared to SNEJF's ROE of +0.14%. Regarding short-term risk, PCRFF is less volatile compared to SNEJF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SONY has a market cap of 148.65B. Regarding current trading prices, PCRFF is priced at $12.32, while SONY trades at $24.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SONY's P/E ratio is 19.14. In terms of profitability, PCRFF's ROE is +0.05%, compared to SONY's ROE of +0.14%. Regarding short-term risk, PCRFF is more volatile compared to SONY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, FIS has a market cap of 41.17B. Regarding current trading prices, PCRFF is priced at $12.32, while FIS trades at $78.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas FIS's P/E ratio is 49.91. In terms of profitability, PCRFF's ROE is +0.05%, compared to FIS's ROE of +0.09%. Regarding short-term risk, PCRFF is more volatile compared to FIS. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SWDHY has a market cap of 26.96B. Regarding current trading prices, PCRFF is priced at $12.32, while SWDHY trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SWDHY's P/E ratio is 10.89. In terms of profitability, PCRFF's ROE is +0.05%, compared to SWDHY's ROE of +0.07%. Regarding short-term risk, PCRFF is less volatile compared to SWDHY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, PCRFY has a market cap of 21.85B. Regarding current trading prices, PCRFF is priced at $12.32, while PCRFY trades at $9.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas PCRFY's P/E ratio is 6.59. In terms of profitability, PCRFF's ROE is +0.05%, compared to PCRFY's ROE of +0.07%. Regarding short-term risk, PCRFF is more volatile compared to PCRFY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, KYOCY has a market cap of 16.82B. Regarding current trading prices, PCRFF is priced at $12.32, while KYOCY trades at $11.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas KYOCY's P/E ratio is 85.29. In terms of profitability, PCRFF's ROE is +0.05%, compared to KYOCY's ROE of +0.01%. Regarding short-term risk, PCRFF is more volatile compared to KYOCY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, KYOCF has a market cap of 16.34B. Regarding current trading prices, PCRFF is priced at $12.32, while KYOCF trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas KYOCF's P/E ratio is 82.86. In terms of profitability, PCRFF's ROE is +0.05%, compared to KYOCF's ROE of +0.03%. Regarding short-term risk, PCRFF is less volatile compared to KYOCF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, JVCZY has a market cap of 6.94B. Regarding current trading prices, PCRFF is priced at $12.32, while JVCZY trades at $46.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas JVCZY's P/E ratio is 15.70. In terms of profitability, PCRFF's ROE is +0.05%, compared to JVCZY's ROE of +0.10%. Regarding short-term risk, PCRFF is less volatile compared to JVCZY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SHCAY has a market cap of 4.10B. Regarding current trading prices, PCRFF is priced at $12.32, while SHCAY trades at $1.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SHCAY's P/E ratio is -3.95. In terms of profitability, PCRFF's ROE is +0.05%, compared to SHCAY's ROE of -1.06%. Regarding short-term risk, PCRFF is less volatile compared to SHCAY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SHCAF has a market cap of 4.07B. Regarding current trading prices, PCRFF is priced at $12.32, while SHCAF trades at $6.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SHCAF's P/E ratio is -3.94. In terms of profitability, PCRFF's ROE is +0.05%, compared to SHCAF's ROE of -0.83%. Regarding short-term risk, PCRFF is less volatile compared to SHCAF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, TCLHF has a market cap of 3.25B. Regarding current trading prices, PCRFF is priced at $12.32, while TCLHF trades at $1.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas TCLHF's P/E ratio is 14.33. In terms of profitability, PCRFF's ROE is +0.05%, compared to TCLHF's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to TCLHF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, LPL has a market cap of 3.10B. Regarding current trading prices, PCRFF is priced at $12.32, while LPL trades at $3.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas LPL's P/E ratio is -1.56. In terms of profitability, PCRFF's ROE is +0.05%, compared to LPL's ROE of -0.35%. Regarding short-term risk, PCRFF is more volatile compared to LPL. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, VZIO has a market cap of 2.30B. Regarding current trading prices, PCRFF is priced at $12.32, while VZIO trades at $11.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas VZIO's P/E ratio is 162.14. In terms of profitability, PCRFF's ROE is +0.05%, compared to VZIO's ROE of +0.00%. Regarding short-term risk, PCRFF is more volatile compared to VZIO. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, CSIOF has a market cap of 1.91B. Regarding current trading prices, PCRFF is priced at $12.32, while CSIOF trades at $8.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas CSIOF's P/E ratio is 46.44. In terms of profitability, PCRFF's ROE is +0.05%, compared to CSIOF's ROE of +0.05%. Regarding short-term risk, PCRFF is less volatile compared to CSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, CSIOY has a market cap of 1.70B. Regarding current trading prices, PCRFF is priced at $12.32, while CSIOY trades at $74.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas CSIOY's P/E ratio is 39.56. In terms of profitability, PCRFF's ROE is +0.05%, compared to CSIOY's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to CSIOY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SONO has a market cap of 1.24B. Regarding current trading prices, PCRFF is priced at $12.32, while SONO trades at $10.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SONO's P/E ratio is -18.96. In terms of profitability, PCRFF's ROE is +0.05%, compared to SONO's ROE of -0.15%. Regarding short-term risk, PCRFF is less volatile compared to SONO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, AITUY has a market cap of 1.17B. Regarding current trading prices, PCRFF is priced at $12.32, while AITUY trades at $9.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas AITUY's P/E ratio is 18.53. In terms of profitability, PCRFF's ROE is +0.05%, compared to AITUY's ROE of +0.05%. Regarding short-term risk, PCRFF is less volatile compared to AITUY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SNCPF has a market cap of 957.41M. Regarding current trading prices, PCRFF is priced at $12.32, while SNCPF trades at $43.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SNCPF's P/E ratio is 7.90. In terms of profitability, PCRFF's ROE is +0.05%, compared to SNCPF's ROE of +0.02%. Regarding short-term risk, PCRFF is more volatile compared to SNCPF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, SWDHF has a market cap of 936.72M. Regarding current trading prices, PCRFF is priced at $12.32, while SWDHF trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas SWDHF's P/E ratio is 6.00. In terms of profitability, PCRFF's ROE is +0.05%, compared to SWDHF's ROE of +0.06%. Regarding short-term risk, PCRFF is more volatile compared to SWDHF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, HEAR has a market cap of 357.41M. Regarding current trading prices, PCRFF is priced at $12.32, while HEAR trades at $17.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas HEAR's P/E ratio is 57.42. In terms of profitability, PCRFF's ROE is +0.05%, compared to HEAR's ROE of +0.04%. Regarding short-term risk, PCRFF is less volatile compared to HEAR. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, BGOUF has a market cap of 283.53M. Regarding current trading prices, PCRFF is priced at $12.32, while BGOUF trades at $1.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas BGOUF's P/E ratio is -32.47. In terms of profitability, PCRFF's ROE is +0.05%, compared to BGOUF's ROE of -0.06%. Regarding short-term risk, PCRFF is less volatile compared to BGOUF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, TBCH has a market cap of 215.65M. Regarding current trading prices, PCRFF is priced at $12.32, while TBCH trades at $10.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas TBCH's P/E ratio is 13.74. In terms of profitability, PCRFF's ROE is +0.05%, compared to TBCH's ROE of +0.14%. Regarding short-term risk, PCRFF is less volatile compared to TBCH. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, VOXX has a market cap of 168.96M. Regarding current trading prices, PCRFF is priced at $12.32, while VOXX trades at $7.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas VOXX's P/E ratio is -2.43. In terms of profitability, PCRFF's ROE is +0.05%, compared to VOXX's ROE of -0.25%. Regarding short-term risk, PCRFF is more volatile compared to VOXX. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, VUZI has a market cap of 147.91M. Regarding current trading prices, PCRFF is priced at $12.32, while VUZI trades at $1.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas VUZI's P/E ratio is -1.80. In terms of profitability, PCRFF's ROE is +0.05%, compared to VUZI's ROE of -1.59%. Regarding short-term risk, PCRFF is less volatile compared to VUZI. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, ADPXY has a market cap of 116.42M. Regarding current trading prices, PCRFF is priced at $12.32, while ADPXY trades at $2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas ADPXY's P/E ratio is -13.36. In terms of profitability, PCRFF's ROE is +0.05%, compared to ADPXY's ROE of +1.75%. Regarding short-term risk, PCRFF is less volatile compared to ADPXY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, GPRO has a market cap of 98.47M. Regarding current trading prices, PCRFF is priced at $12.32, while GPRO trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas GPRO's P/E ratio is -0.22. In terms of profitability, PCRFF's ROE is +0.05%, compared to GPRO's ROE of -2.32%. Regarding short-term risk, PCRFF is less volatile compared to GPRO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, VTEPF has a market cap of 92.23M. Regarding current trading prices, PCRFF is priced at $12.32, while VTEPF trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas VTEPF's P/E ratio is -0.43. In terms of profitability, PCRFF's ROE is +0.05%, compared to VTEPF's ROE of -0.19%. Regarding short-term risk, PCRFF is more volatile compared to VTEPF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, UEIC has a market cap of 83.21M. Regarding current trading prices, PCRFF is priced at $12.32, while UEIC trades at $6.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas UEIC's P/E ratio is -3.42. In terms of profitability, PCRFF's ROE is +0.05%, compared to UEIC's ROE of -0.15%. Regarding short-term risk, PCRFF is less volatile compared to UEIC. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, HLOC has a market cap of 69.37M. Regarding current trading prices, PCRFF is priced at $12.32, while HLOC trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas HLOC's P/E ratio is -16.00. In terms of profitability, PCRFF's ROE is +0.05%, compared to HLOC's ROE of +0.50%. Regarding short-term risk, PCRFF is more volatile compared to HLOC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, KOSS has a market cap of 46.13M. Regarding current trading prices, PCRFF is priced at $12.32, while KOSS trades at $4.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas KOSS's P/E ratio is -70.29. In terms of profitability, PCRFF's ROE is +0.05%, compared to KOSS's ROE of -0.02%. Regarding short-term risk, PCRFF is less volatile compared to KOSS. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, BWSN has a market cap of 45.73M. Regarding current trading prices, PCRFF is priced at $12.32, while BWSN trades at $11.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas BWSN's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to BWSN's ROE of +0.26%. Regarding short-term risk, PCRFF is less volatile compared to BWSN. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, AXIL has a market cap of 41.89M. Regarding current trading prices, PCRFF is priced at $12.32, while AXIL trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas AXIL's P/E ratio is 27.39. In terms of profitability, PCRFF's ROE is +0.05%, compared to AXIL's ROE of +0.14%. Regarding short-term risk, PCRFF is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, FOXX has a market cap of 41.69M. Regarding current trading prices, PCRFF is priced at $12.32, while FOXX trades at $5.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas FOXX's P/E ratio is -13.63. In terms of profitability, PCRFF's ROE is +0.05%, compared to FOXX's ROE of +3.10%. Regarding short-term risk, PCRFF is less volatile compared to FOXX. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, BWNB has a market cap of 41.28M. Regarding current trading prices, PCRFF is priced at $12.32, while BWNB trades at $6.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas BWNB's P/E ratio is -4.05. In terms of profitability, PCRFF's ROE is +0.05%, compared to BWNB's ROE of +0.26%. Regarding short-term risk, PCRFF is less volatile compared to BWNB. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, DBOXF has a market cap of 28.63M. Regarding current trading prices, PCRFF is priced at $12.32, while DBOXF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas DBOXF's P/E ratio is 12.90. In terms of profitability, PCRFF's ROE is +0.05%, compared to DBOXF's ROE of +0.30%. Regarding short-term risk, PCRFF is more volatile compared to DBOXF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, HAPBF has a market cap of 24.03M. Regarding current trading prices, PCRFF is priced at $12.32, while HAPBF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas HAPBF's P/E ratio is -4.70. In terms of profitability, PCRFF's ROE is +0.05%, compared to HAPBF's ROE of +2.21%. Regarding short-term risk, PCRFF is less volatile compared to HAPBF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, CHWTF has a market cap of 19.66M. Regarding current trading prices, PCRFF is priced at $12.32, while CHWTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas CHWTF's P/E ratio is -0.12. In terms of profitability, PCRFF's ROE is +0.05%, compared to CHWTF's ROE of -0.13%. Regarding short-term risk, PCRFF is more volatile compared to CHWTF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, FEBO has a market cap of 14.71M. Regarding current trading prices, PCRFF is priced at $12.32, while FEBO trades at $1.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas FEBO's P/E ratio is -33.25. In terms of profitability, PCRFF's ROE is +0.05%, compared to FEBO's ROE of -0.05%. Regarding short-term risk, PCRFF is more volatile compared to FEBO. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, ZEPP has a market cap of 9.27M. Regarding current trading prices, PCRFF is priced at $12.32, while ZEPP trades at $2.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas ZEPP's P/E ratio is -0.56. In terms of profitability, PCRFF's ROE is +0.05%, compared to ZEPP's ROE of -0.18%. Regarding short-term risk, PCRFF is less volatile compared to ZEPP. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, MSN has a market cap of 8.63M. Regarding current trading prices, PCRFF is priced at $12.32, while MSN trades at $0.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas MSN's P/E ratio is -2.73. In terms of profitability, PCRFF's ROE is +0.05%, compared to MSN's ROE of -0.13%. Regarding short-term risk, PCRFF is more volatile compared to MSN. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, PXDT has a market cap of 8.62M. Regarding current trading prices, PCRFF is priced at $12.32, while PXDT trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas PXDT's P/E ratio is -0.65. In terms of profitability, PCRFF's ROE is +0.05%, compared to PXDT's ROE of -1.28%. Regarding short-term risk, PCRFF is more volatile compared to PXDT. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, MICS has a market cap of 7.21M. Regarding current trading prices, PCRFF is priced at $12.32, while MICS trades at $0.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas MICS's P/E ratio is -0.50. In terms of profitability, PCRFF's ROE is +0.05%, compared to MICS's ROE of -2.30%. Regarding short-term risk, PCRFF is less volatile compared to MICS. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, WTO has a market cap of 6.45M. Regarding current trading prices, PCRFF is priced at $12.32, while WTO trades at $1.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas WTO's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.05%, compared to WTO's ROE of -0.47%. Regarding short-term risk, PCRFF is less volatile compared to WTO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, RIME has a market cap of 6.35M. Regarding current trading prices, PCRFF is priced at $12.32, while RIME trades at $2.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas RIME's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.05%, compared to RIME's ROE of +41.53%. Regarding short-term risk, PCRFF is less volatile compared to RIME. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, UTME has a market cap of 6.28M. Regarding current trading prices, PCRFF is priced at $12.32, while UTME trades at $0.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas UTME's P/E ratio is -0.42. In terms of profitability, PCRFF's ROE is +0.05%, compared to UTME's ROE of -1.61%. Regarding short-term risk, PCRFF is less volatile compared to UTME. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, WLDS has a market cap of 1.43M. Regarding current trading prices, PCRFF is priced at $12.32, while WLDS trades at $1.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas WLDS's P/E ratio is -0.06. In terms of profitability, PCRFF's ROE is +0.05%, compared to WLDS's ROE of -2.84%. Regarding short-term risk, PCRFF is less volatile compared to WLDS. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, WLDSW has a market cap of 1.29M. Regarding current trading prices, PCRFF is priced at $12.32, while WLDSW trades at $1.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas WLDSW's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to WLDSW's ROE of -2.84%. Regarding short-term risk, PCRFF is more volatile compared to WLDSW. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, AMOSF has a market cap of 39044.00. Regarding current trading prices, PCRFF is priced at $12.32, while AMOSF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas AMOSF's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.05%, compared to AMOSF's ROE of -8.40%. Regarding short-term risk, PCRFF is more volatile compared to AMOSF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, NUHRF has a market cap of 27054.00. Regarding current trading prices, PCRFF is priced at $12.32, while NUHRF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas NUHRF's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to NUHRF's ROE of -3.48%. Regarding short-term risk, PCRFF is less volatile compared to NUHRF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, GAXY has a market cap of 23306.00. Regarding current trading prices, PCRFF is priced at $12.32, while GAXY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas GAXY's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.05%, compared to GAXY's ROE of +4.24%. Regarding short-term risk, PCRFF is more volatile compared to GAXY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, COLCF has a market cap of 8252.00. Regarding current trading prices, PCRFF is priced at $12.32, while COLCF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas COLCF's P/E ratio is -0.04. In terms of profitability, PCRFF's ROE is +0.05%, compared to COLCF's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to COLCF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, ANDR has a market cap of 6811.00. Regarding current trading prices, PCRFF is priced at $12.32, while ANDR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas ANDR's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.05%, compared to ANDR's ROE of +0.13%. Regarding short-term risk, PCRFF is more volatile compared to ANDR. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, BZIC has a market cap of 6750.00. Regarding current trading prices, PCRFF is priced at $12.32, while BZIC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas BZIC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.05%, compared to BZIC's ROE of N/A. Regarding short-term risk, PCRFF is more volatile compared to BZIC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, NGEY has a market cap of 5732.00. Regarding current trading prices, PCRFF is priced at $12.32, while NGEY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas NGEY's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to NGEY's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to NGEY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, CTXV has a market cap of 2450.00. Regarding current trading prices, PCRFF is priced at $12.32, while CTXV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas CTXV's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to CTXV's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to CTXV. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, PUMD has a market cap of 1861.00. Regarding current trading prices, PCRFF is priced at $12.32, while PUMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas PUMD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to PUMD's ROE of N/A. Regarding short-term risk, PCRFF is more volatile compared to PUMD. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, ZVTK has a market cap of 1407.00. Regarding current trading prices, PCRFF is priced at $12.32, while ZVTK trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas ZVTK's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to ZVTK's ROE of +0.00%. Regarding short-term risk, PCRFF is less volatile compared to ZVTK. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, GAXYQ has a market cap of 1165.00. Regarding current trading prices, PCRFF is priced at $12.32, while GAXYQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas GAXYQ's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.05%, compared to GAXYQ's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to GAXYQ. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, LTEC has a market cap of 486.00. Regarding current trading prices, PCRFF is priced at $12.32, while LTEC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas LTEC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.05%, compared to LTEC's ROE of -2.97%. Regarding short-term risk, PCRFF is more volatile compared to LTEC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, CYRD has a market cap of 343.00. Regarding current trading prices, PCRFF is priced at $12.32, while CYRD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas CYRD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to CYRD's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to CYRD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.

PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PCRFF stands at 28.76B. In comparison, NYXO has a market cap of 242.00. Regarding current trading prices, PCRFF is priced at $12.32, while NYXO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PCRFF currently has a P/E ratio of 12.44, whereas NYXO's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.05%, compared to NYXO's ROE of +5.00%. Regarding short-term risk, PCRFF is less volatile compared to NYXO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.